The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Open accessAbstract
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons (ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for Radiotherapy and Oncology (ESTRO) task force brought together experts to update previous 2009 ERS/ESTS guidelines on management of malignant pleural mesothelioma (MPM), a rare cancer with globally poor outcome, after a systematic review of the 2009–2018 literature. The evidence was appraised using the Grading of Recommendations, Assessment, Development and Evaluation approach. The evidence syntheses were discussed and recommendations formulated by this multidisciplinary group of experts. Diagnosis: pleural biopsies remain the gold standard to confirm the diagnosis, usually obtained by thoracoscopy but occasionally via image-guided percutaneous needle biopsy in cases of pleural symphysis or poor performance status. Pathology: standard staining procedures are insufficient in ∼10% of cases, justifying the use of specific markers, including BAP-1 and CDKN2A(p16) for the separation of atypical mesothelial proliferation from MPM. Staging: in the absence of a uniform, robust and validated staging system, we advise using the most recent 2016 8th TNM (tumour, node, metastasis) classification, with an algorithm for pre-therapeutic assessment. Monitoring: patient's performance status, histological subtype and tumour volume are the main prognostic factors of clinical importance in routine MPM management. Other potential parameters should be recorded at baseline and reported in clinical trials. Treatment: (chemo)therapy has limited efficacy in MPM patients and only selected patients are candidates for radical surgery. New promising targeted therapies, immunotherapies and strategies have been reviewed. Because of limited data on the best combination treatment, we emphasise that patients who are considered candidates for a multimodal approach, including radical surgery, should be treated as part of clinical trials in MPM-dedicated centres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609
Evidence-Based Medicine: How to Practice and Teach EBM
Sackett, D. L. (2000) · Cited by 5,950
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
The National Comprehensive Cancer Network (NCCN).
Wood, E. H. (2004) · Journal of the Medical Library Association JMLA · Cited by 2,845
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Postow, M. A., Callahan, M. K., Barker, C. A., Yamada, Y., Yuan, J., Kitano, S., Mu, Z., Rasalan, T., Adamow, M., Ritter, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112824 · Cited by 2,087
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Koyama, S., Akbay, E. A., Li, Y. Y., Herter-Sprie, G. S., Buczkowski, K. A., Richards, W. G., Gandhi, L., Redig, A. J., Rodig, S. J., Asahina, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10501 · Cited by 1,580
Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy
Gao, J., Shi, L. Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.069 · Cited by 1,300
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Voron, T., Colussi, O., Marcheteau, E., Pernot, S., Nizard, M., Pointet, A.-L., Latreche, S., Bergaya, S., Benhamouda, N., Tanchot, C., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20140559 · Cited by 1,179
Germline BAP1 Mutations Predispose to Malignant Mesothelioma
Testa, J. R., Cheung, M., Pei, J., Below, J. E., Tan, Y., Sementino, E., Cox, N. J., Dogan, A. U., Pass, H. I., Trusa, S., et al. (2011) · Nature Genetics · doi:10.1038/ng.912 · Cited by 1,076
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Zalcman, G., Mazieres, J., Margery, J., Greillier, L., Audigier-Valette, C., Moro-Sibilot, D., Molinier, O., Corre, R., Monnet, I., Gounant, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01238-6 · Cited by 968
Self-citationBueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
The European mesothelioma epidemic
Peto, J., Decarli, A., Vecchia, C. L., Levi, F., & Negri, E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690105 · Cited by 891
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42.
(1987) · PubMed · Cited by 851
van Zandwijk, N., Pavlakis, N., Kao, S. C., Linton, A., Boyer, M. J., Clarke, S., Huynh, Y., Chrzanowska, A., Fulham, M. J., Bailey, D. L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30621-6 · Cited by 710
Treasure, T., Lang-Lazdunski, L., Waller, D., Bliss, J. M., Tan, C., Entwisle, J., Snee, M., O'Brien, M., Thomas, G., Senan, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70149-8 · Cited by 708
Self-citationScherpereel, A., Astoul, P., Baas, P., Berghmans, T., Clayson, H., de Vuyst, P., Dienemann, H., Galateau-Salle, F., Hennequin, C., Hillerdal, G., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00063109 · Cited by 638
Self-citationHusain, Colby, Ordóñez, Allen, Attanoos, Beasley, Butnor, Chirieac, Churg, Dacic, et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0124-ra · Cited by 619
Carbone, M., Yang, H., Pass, H. I., Krausz, T., Testa, J. R., & Gaudino, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3459 · Cited by 590
Curran, D., Sahmoud, T., Therasse, P., van Meerbeeck, J., Postmus, P. E., & Giaccone, G. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.145 · Cited by 543
Self-citationMesothelin-family proteins and diagnosis of mesothelioma
Robinson, B. W., Creaney, J., Lake, R., Nowak, A., Musk, A. W., de Klerk, N., Winzell, P., Hellstrom, K. E., & Hellstrom, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14794-0 · Cited by 534
Herndon, J. E., Green, M. R., Chahinian, A. P., Corson, J. M., Suzuki, Y., & Vogelzang, N. J. (1998) · Chest · doi:10.1378/chest.113.3.723 · Cited by 504
Alley, E. W., Lopez, J., Santoro, A., Morosky, A., Saraf, S., Piperdi, B., & van Brummelen, E. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30169-9 · Cited by 490
Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline
Lutz, S., Balboni, T., Jones, J., Lo, S., Petit, J., Rich, S. E., Wong, R., & Hahn, C. (2017) · Practical Radiation Oncology · doi:10.1016/j.prro.2016.08.001 · Cited by 465
Boutin, C., Rey, F., & Viallat, J.-R. (1995) · Chest · doi:10.1378/chest.108.3.754 · Cited by 464
Scherpereel, A., Mazieres, J., Greillier, L., Lantuejoul, S., Dô, P., Bylicki, O., Monnet, I., Corre, R., Audigier-Valette, C., Locatelli-Sanchez, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30765-4 · Cited by 454
Self-citationMaio, M., Scherpereel, A., Calabrò, L., Aerts, J., Perez, S. C., Bearz, A., Nackaerts, K., Fennell, D. A., Kowalski, D., Tsao, A. S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30446-1 · Cited by 424
Self-citationKindler, H. L., Ismaila, N., Armato, S. G., Bueno, R., Hesdorffer, M., Jahan, T., Jones, C. M., Miettinen, M., Pass, H., Rimner, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.6394 · Cited by 420
Baas, P., Fennell, D., Kerr, K. M., Van Schil, P. E., Haas, R. L., & Peters, S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv199 · Cited by 417
Self-citationNuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Serrels, A., Lund, T., Serrels, B., Byron, A., McPherson, R. C., von Kriegsheim, A., Gómez-Cuadrado, L., Canel, M., Muir, M., Ring, J. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.001 · Cited by 407
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
Delgermaa, V., Takahashi, K., Park, E.-K., Le, G. V., Hara, T., & Sorahan, T. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.086678 · Cited by 405
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
Bononi, A., Giorgi, C., Patergnani, S., Larson, D., Verbruggen, K., Tanji, M., Pellegrini, L., Signorato, V., Olivetto, F., Pastorino, S., et al. (2017) · Nature · doi:10.1038/nature22798 · Cited by 401
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014
Mokdad, A. H., Dwyer-Lindgren, L., Fitzmaurice, C., Stubbs, R. W., Bertozzi-Villa, A., Morozoff, C., Charara, R., Allen, C., Naghavi, M., & Murray, C. J. L. (2017) · JAMA · doi:10.1001/jama.2016.20324 · Cited by 397
Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
Rahman, N. M., Ali, N. J., Brown, G., Chapman, S. J., Davies, R. J. O., Downer, N. J., Gleeson, F. V., Howes, T. Q., Treasure, T., Singh, S., et al. (2010) · Thorax · doi:10.1136/thx.2010.137018 · Cited by 392
Loss of BAP1 function leads to EZH2-dependent transformation
LaFave, L. M., Béguelin, W., Koche, R., Teater, M., Spitzer, B., Chramiec, A., Papalexi, E., Keller, M. D., Hricik, T., Konstantinoff, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3947 · Cited by 381
Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels
Pass, H. I., Lott, D., Lonardo, F., Harbut, M., Liu, Z., Tang, N., Carbone, M., Webb, C., & Wali, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051185 · Cited by 357
Calabrò, L., Morra, A., Fonsatti, E., Cutaia, O., Amato, G., Giannarelli, D., Di Giacomo, A. M., Danielli, R., Altomonte, M., Mutti, L., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70381-4 · Cited by 356
Self-citationMaskell, N., Gleeson, F., & Davies, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13079-6 · Cited by 345
Self-citationCarcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes
Grosse, Y., Loomis, D., Guyton, K. Z., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Scoccianti, C., Mattock, H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71109-x · Cited by 344
Novel Insights into Mesothelioma Biology and Implications for Therapy
Yap, T. A., Aerts, J. G., Popat, S., & Fennell, D. A. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.42 · Cited by 324
Self-citationMalignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Bibby, A. C., Tsim, S., Kanellakis, N., Ball, H., Talbot, D. C., Blyth, K. G., Maskell, N. A., & Psallidas, I. (2016) · European Respiratory Review · doi:10.1183/16000617.0063-2016 · Cited by 316
Self-citationERS/EACTS statement on the management of malignant pleural effusions
Bibby, A. C., Dorn, P., Psallidas, I., Porcel, J. M., Janssen, J., Froudarakis, M., Subotic, D., Astoul, P., Licht, P., Schmid, R., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00349-2018 · Cited by 316
Self-citationInitial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
Rusch, V. W., Giroux, D., Kennedy, C., Ruffini, E., Cangir, A. K., Rice, D., Pass, H., Asamura, H., Waller, D., Edwards, J., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826915f1 · Cited by 308
Self-citationFibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
Pass, H. I., Levin, S. M., Harbut, M. R., Melamed, J., Chiriboga, L., Donington, J., Huflejt, M., Carbone, M., Chia, D., Goodglick, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1115050 · Cited by 283
Galateau-Salle, F., Churg, A., Roggli, V., & Travis, W. D. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.11.005 · Cited by 282
Self-citationRice, D., Rusch, V., Pass, H., Asamura, H., Nakano, T., Edwards, J., Giroux, D. J., Hasegawa, S., Kernstine, K. H., Waller, D., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182208e3f · Cited by 269
Self-citationOccupation and cancer in Britain
Rushton, L., Bagga, S., Bevan, R., Brown, T. P., Cherrie, J. W., Holmes, P., Fortunato, L., Slack, R., Van Tongeren, M., Young, C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605637 · Cited by 265
Muers, M. F., Stephens, R. J., Fisher, P., Darlison, L., Higgs, C. M., Lowry, E., Nicholson, A. G., O'Brien, M., Peake, M., Rudd, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60727-8 · Cited by 260
Kindler, H. L., Karrison, T. G., Gandara, D. R., Lu, C., Krug, L. M., Stevenson, J. P., Jänne, P. A., Quinn, D. I., Koczywas, M. N., Brahmer, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5869 · Cited by 257
Non-asbestos-related malignant mesothelioma. A review
Peterson, J. T., Greenberg, S. D., & Buffler, P. A. (1984) · Cancer · doi:10.1002/1097-0142(19840901)54:5<951::aid-cncr2820540536>3.0.co;2-a · Cited by 254
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival
Baumann, F., Flores, E., Napolitano, A., Kanodia, S., Taioli, E., Pass, H., Yang, H., & Carbone, M. (2015) · Carcinogenesis · doi:10.1093/carcin/bgu227 · Cited by 254
(1992) · PubMed · Cited by 252
Disselhorst, M. J., Quispel-Janssen, J., Lalezari, F., Monkhorst, K., de Vries, J. F., van der Noort, V., Harms, E., Burgers, S., & Baas, P. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30420-x · Cited by 250
&NA; (2003) · Journal of Bronchology · doi:10.1097/00128594-200307000-00026 · Cited by 250
A Meta-Analysis of Asbestos-Related Cancer Risk That Addresses Fiber Size and Mineral Type
Berman, D. W., & Crump, K. S. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440802273156 · Cited by 246
Lin, R.-T., Takahashi, K., Karjalainen, A., Hoshuyama, T., Wilson, D., Kameda, T., Chan, C.-C., Wen, C.-P., Furuya, S., Higashi, T., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60412-7 · Cited by 239
Hollevoet, K., Reitsma, J. B., Creaney, J., Grigoriu, B. D., Robinson, B. W., Scherpereel, A., Cristaudo, A., Pass, H. I., Nackaerts, K., Rodríguez Portal, J. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6671 · Cited by 230
Self-citationFrequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
Panou, V., Gadiraju, M., Wolin, A., Weipert, C. M., Skarda, E., Husain, A. N., Patel, J. D., Rose, B., Zhang, S. R., Weatherly, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.5204 · Cited by 229
Rintoul, R. C., Ritchie, A. J., Edwards, J. G., Waller, D. A., Coonar, A. S., Bennett, M., Lovato, E., Hughes, V., Fox-Rushby, J. A., & Sharples, L. D. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60418-9 · Cited by 224
Self-citationWoolhouse, I., Bishop, L., Darlison, L., De Fonseka, D., Edey, A., Edwards, J., Faivre-Finn, C., Fennell, D. A., Holmes, S., Kerr, K. M., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-211321 · Cited by 221
Self-citationCalabrò, L., Morra, A., Giannarelli, D., Amato, G., D'Incecco, A., Covre, A., Lewis, A., Rebelatto, M. C., Danielli, R., Altomonte, M., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30151-6 · Cited by 218
Krug, L. M., Kindler, H. L., Calvert, H., Manegold, C., Tsao, A. S., Fennell, D., Öhman, R., Plummer, R., Eberhardt, W. E. E., Fukuoka, K., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70056-2 · Cited by 215
Self-citationErionite exposure in North Dakota and Turkish villages with mesothelioma
Carbone, M., Baris, Y. I., Bertino, P., Brass, B., Comertpay, S., Dogan, A. U., Gaudino, G., Jube, S., Kanodia, S., Partridge, C. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105887108 · Cited by 211
Rusch, V. W., Chansky, K., Kindler, H. L., Nowak, A. K., Pass, H. I., Rice, D. C., Shemanski, L., Galateau-Sallé, F., McCaughan, B. C., Nakano, T., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.09.124 · Cited by 207
Self-citationCalabrò, L., Morra, A., Fonsatti, E., Cutaia, O., Fazio, C., Annesi, D., Lenoci, M., Amato, G., Danielli, R., Altomonte, M., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00092-2 · Cited by 206
Stahel, R. A., Riesterer, O., Xyrafas, A., Opitz, I., Beyeler, M., Ochsenbein, A., Früh, M., Cathomas, R., Nackaerts, K., Peters, S., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00208-9 · Cited by 202
Self-citationSzlosarek, P. W., Steele, J. P., Nolan, L., Gilligan, D., Taylor, P., Spicer, J., Lind, M., Mitra, S., Shamash, J., Phillips, M. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3049 · Cited by 201
Self-citationInvestigating unilateral pleural effusions: the role of cytology
Arnold, D. T., De Fonseka, D., Perry, S., Morley, A., Harvey, J. E., Medford, A., Brett, M., & Maskell, N. A. (2018) · European Respiratory Journal · doi:10.1183/13993003.01254-2018 · Cited by 198
Self-citationBueno, C. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.6.1190 · Cited by 194
Rimner, A., Zauderer, M. G., Gomez, D. R., Adusumilli, P. S., Parhar, P. K., Wu, A. J., Woo, K. M., Shen, R., Ginsberg, M. S., Yorke, E. D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.2675 · Cited by 190
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Røe, O. D., & Stella, G. M. (2015) · European Respiratory Review · doi:10.1183/09059180.00007014 · Cited by 185
Szlosarek, P. W., Klabatsa, A., Pallaska, A., Sheaff, M., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P., Rudd, R. M., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181
Self-citationA randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
O’Rourke, N., Garcia, J. C., Paul, J., Lawless, C., McMenemin, R., & Hill, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.022 · Cited by 180
Hassan, R., Kindler, H. L., Jahan, T., Bazhenova, L., Reck, M., Thomas, A., Pastan, I., Parno, J., O'Shannessy, D. J., Fatato, P., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0804 · Cited by 180
Bydder, S., Phillips, M., Joseph, D. J., Cameron, F., Spry, N. A., DeMelker, Y., & Musk, A. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601957 · Cited by 179
Rice, D., Chansky, K., Nowak, A., Pass, H., Kindler, H., Shemanski, L., Opitz, I., Call, S., Hasegawa, S., Kernstine, K., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.09.121 · Cited by 175
Self-citationNowak, A. K., Chansky, K., Rice, D. C., Pass, H. I., Kindler, H. L., Shemanski, L. R., Billè, A., Rintoul, R. C., Batırel, H. F., Thomas, C. F., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.08.147 · Cited by 172
Self-citationErasmus, J. J., Truong, M. T., Smythe, W. R., Munden, R. F., Marom, E. M., Rice, D. C., Vaporciyan, A. A., Walsh, G. L., Sabloff, B. S., Broemeling, L. D., et al. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.10.034 · Cited by 171
Lee, H. Y., Hyun, S. H., Lee, K. S., Kim, B.-T., Kim, J., Shim, Y. M., Ahn, M.-J., Kim, T. S., Yi, C. A., & Chung, M. J. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1107-z · Cited by 171
Scagliotti, G. V., Gaafar, R., Nowak, A. K., Nakano, T., van Meerbeeck, J., Popat, S., Vogelzang, N. J., Grosso, F., Aboelhassan, R., Jakopovic, M., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30139-0 · Cited by 168
Self-citationNicholson, A. G., Sauter, J. L., Nowak, A. K., Kindler, H. L., Gill, R. R., Remy-Jardin, M., Armato, S. G., Fernandez-Cuesta, L., Bueno, R., Alcala, N., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.2506 · Cited by 168
Self-citationHwang, H. C., Sheffield, B. S., Rodriguez, S., Thompson, K., Tse, C. H., Gown, A. M., & Churg, A. (2016) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000529 · Cited by 166
Clive, A. O., Taylor, H., Dobson, L., Wilson, P., de Winton, E., Panakis, N., Pepperell, J., Howell, T., Stewart, S. A., Penz, E., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30095-x · Cited by 166
Self-citationMesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008
Henley, S. J., Larson, T. C., III, Wu, M., Antao, V. C., Lewis, M., Pinheiro, G. A., & Eheman, C. R. (2013) · International Journal of Occupational and Environmental Health · doi:10.1179/2049396712y.0000000016 · Cited by 164
Lacourt, A., Gramond, C., Rolland, P., Ducamp, S., Audignon‐Durand, S., Astoul, P. J., Chamming’s, S., Ilg, A. G. S., Rinaldo, M., Rahérison, C., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2013-203744 · Cited by 163
Self-citationBrims, F. J. H., Meniawy, T. M., Duffus, I., de Fonseka, D., Segal, A., Creaney, J., Maskell, N., Lake, R. A., de Klerk, N., & Nowak, A. K. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.12.108 · Cited by 160
Self-citationEstimation of the global burden of mesothelioma deaths from incomplete national mortality data
Odgerel, C.-O., Takahashi, K., Sorahan, T., Driscoll, T., Fitzmaurice, C., Yoko-o, M., Sawanyawisuth, K., Furuya, S., Tanaka, F., Horie, S., et al. (2017) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104298 · Cited by 160
Ramalingam, S. S., Belani, C. P., Ruel, C., Frankel, P., Gitlitz, B., Koczywas, M., Espinoza-Delgado, I., & Gandara, D. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318191520c · Cited by 159
Suzui, M., Futakuchi, M., Fukamachi, K., Numano, T., Abdelgied, M., Takahashi, S., Ohnishi, M., Omori, T., Tsuruoka, S., Hirose, A., et al. (2016) · Cancer Science · doi:10.1111/cas.12954 · Cited by 159
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
Stebbing, J., Powles, T. B., McPherson, K., Shamash, J., Wells, P., Sheaff, M. T., Slater, S., Rudd, R., Fennell, D. A., & Steele, J. P. C. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.001 · Cited by 155
Self-citationNovel therapies for malignant pleural mesothelioma
Scherpereel, A., Wallyn, F., Albelda, S. Μ., & Munck, C. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30100-1 · Cited by 149
Self-citationComparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Creaney, J., Dick, I. M., Meniawy, T. M., Leong, S. L., Leon, J. S., Demelker, Y., Segal, A., Musk, A. W., Lee, G., Skates, S. J., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205205 · Cited by 146
Grosso, F., Steele, N. L., Novello, S., Nowak, A. K., Popat, S., Greillier, L., John, T., Leighl, N. B., Reck, M., Taylor, P., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.9012 · Cited by 146
Self-citationOstroff, R. M., Mehan, M. R., Stewart, A., Ayers, D. G., Brody, E. N., Williams, S. A., Levin, S. M., Black, B., Harbut, M. R., Carbone, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046091 · Cited by 145
Fennell, D. A., Baas, P., Taylor, P., Nowak, A. K., Gilligan, D., Nakano, T., Pachter, J. A., Weaver, D. T., Scherpereel, A., Pavlakis, N., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.0543 · Cited by 142
Self-citationBovolato, P., Casadio, C., Billè, A., Ardissone, F., Santambrogio, L., Ratto, G. B., Garofalo, G., Bedini, A. V., Garassino, M. C., Porcu, L., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000064 · Cited by 141
Armato, S. G., & Nowak, A. K. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.04.034 · Cited by 140
Physician-Based Ultrasound-Guided Biopsy for Diagnosing Pleural Disease
Hallifax, R., Corcoran, J. P., Ahmed, A., Nagendran, M., Rostom, H., Hassan, N., Maruthappu, M., Psallidas, I., Manuel, A. R., Gleeson, F. V., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0299 · Cited by 139
Self-citationOlsen, N. J., Franklin, P. J., Reid, A., Klerk, N. H., Threlfall, T. J., Shilkin, K., & Musk, B. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10125 · Cited by 138
Marinaccio, A., Binazzi, A., Marzio, D. D., Scarselli, A., Verardo, M., Mirabelli, D., Gennaro, V., Mensi, C., Riboldi, L., Merler, E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26229 · Cited by 138
Kirschner, M. B., Cheng, Y. Y., Badrian, B., Kao, S., Creaney, J., Edelman, J. J., Armstrong, N. J., Vallely, M. P., Musk, A. W., Robinson, B. W. S., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182572e83 · Cited by 136
Germline BAP1 mutations induce a Warburg effect
Bononi, A., Yang, H., Giorgi, C., Patergnani, S., Pellegrini, L., Su, M., Xie, G., Signorato, V., Pastorino, S., Morris, P., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.95 · Cited by 133
Adams, R. F., Gray, W., Davies, R. J., et al. (2001) · CHEST Journal · doi:10.1378/chest.120.6.1798 · Cited by 132
Cho, J., Feld, R., Leighl, N. B., Opitz, I., Anraku, M., Tsao, M., Hwang, D. M., Hope, A. J., & de Perrot, M. E. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000078 · Cited by 129
Self-citationAsbestos: use, bans and disease burden in Europe
Kameda, T., Takahashi, K., Kim, R., Jiang, Y., Movahed, M., Park, E.-K., & Rantanen, J. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.13.132118 · Cited by 128
O'Brien, M. E. R., Watkins, D. J., Ryan, C., Priest, K., Corbishley, C. M., Norton, A., Ashley, S., Rowell, N. P., & Sayer, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj073 · Cited by 123
Beddowes, E. J., Spicer, J. F., Chan, P. Y., Khadeir, R. S., Corbacho, J. G., Repana, D., Steele, J. P. C., Schmid, P., Szyszko, T. A., Cook, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.3230 · Cited by 120
Napolitano, A., Antoine, D. J., Pellegrini, L., Baumann, F., Pagano, I., Pastorino, S., Goparaju, C. M. V., Prokrym, K., Canino, C., Pass, H. I., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1130 · Cited by 118
Dubey, S., Janne, P. A., Krug, L. M., Pang, H., Wang, X., Heinze, R., Watt, C., Crawford, J., Kratzke, R. A., Vokes, E. E., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ec18db · Cited by 116
Beebe‐Dimmer, J., Fryzek, J. P., Yee, C. L., Dalvi, T. B., Garabrant, D. H., Schwartz, A. G., & Gadgeel, S. M. (2016) · Clinical Epidemiology · doi:10.2147/clep.s105396 · Cited by 116
Gregorc, V., Zucali, P. A., Santoro, A., Ceresoli, G. L., Citterio, G., Pas, T. M. D., Zilembo, N., Vincenzo, F. D., Simonelli, M., Rossoni, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3649 · Cited by 112
Sugarbaker, D. J., Richards, W. G., & Bueno, R. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000903 · Cited by 111
Epidemiology of Environmental Exposure and Malignant Mesothelioma
Liu, B., van Gerwen, M. A. G., Bonassi, S., & Taioli, E. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.04.002 · Cited by 108
Ceresoli, G. L., Zucali, P. A., Mencoboni, M., Botta, M., Grossi, F., Cortinovis, D. L., Zilembo, N., Ripa, C., Tiseo, M., Favaretto, A. G., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.368 · Cited by 107
Pass, H. I., Giroux, D. J., Kennedy, C. W., Ruffini, E., Cangır, A., Rice, D., Asamura, H., Waller, D. A., Edwards, J. G., Weder, W., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000181 · Cited by 107
Self-citationMcDonald, R. E., Ding, K., Brundage, M., Meyer, R. M., Nabid, A., Chabot, P., Coulombe, G., Ahmed, S., Kuk, J., Dar, A. R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6770 · Cited by 106
The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma
Thapa, B., Salcedo, A., Lin, X., Walkiewicz, M., Murone, C., Ameratunga, M., Asadi, K., Deb, S., Barnett, S. A., Knight, S., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.02.013 · Cited by 106
Nelson, D. B., Rice, D. C., Niu, J., Atay, S. M., Vaporciyan, A. A., Antonoff, M. B., Hofstetter, W. L., Walsh, G. L., Swisher, S. G., Roth, J. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.8401 · Cited by 106
Righi, L., Duregon, E., Vatrano, S., Izzo, S., Giorcelli, J., Rondón‐Lagos, M., Ascoli, V., Ruffini, E., Ventura, L., Volante, M., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.020 · Cited by 105
Park, E., Sandrini, A., Yates, D. H., Creaney, J., Robinson, B. W. S., Thomas, P. S., & Johnson, A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-258oc · Cited by 102
Ferrante, D., Mirabelli, D., Tùnesi, S., Terracini, B., & Magnani, C. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2015-102803 · Cited by 102
Global mesothelioma epidemic: Trend and features
Bianchi, C., & Bianchi, T. (2014) · Indian Journal of Occupational and Environmental Medicine · doi:10.4103/0019-5278.146897 · Cited by 101
Betti, M., Casalone, E., Ferrante, D., Aspesi, A., Morleo, G., Biasi, A., Sculco, M., Mancuso, G., Guarrera, S., Righi, L., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.028 · Cited by 101
Buikhuisen, W. A., Burgers, J. A., Vincent, A. D., Korse, C. M., van Klaveren, R. J., Schramel, F. M. N. H., Pavlakis, N., Nowak, A. K., Custers, F. L. J., Schouwink, J. H., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70125-6 · Cited by 100
Pleural Plaques and the Risk of Pleural Mesothelioma
Pairon, J. ‐., Laurent, F., Rinaldo, M., Clin, B., Andujar, P., Ameille, J., Brochard, P., Chamming’s, S., Ferretti, G., Galateau-Sallé, F., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs513 · Cited by 100
Self-citationValproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study
Scherpereel, A., Berghmans, T., Lafitte, J., Colinet, B., Richez, M., Bonduelle, Y., Meert, A., Dhalluin, X., Leclercq, N., Paesmans, M., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00037310 · Cited by 98
Self-citationPhase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509
Garland, L. L., Chansky, K., Wozniak, A. J., Tsao, A. S., Gadgeel, S. M., Verschraegen, C. F., DaSilva, M. A., Redman, M. W., & Gandara, D. R. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318229586e · Cited by 97
Dowell, J. E., Dunphy, F., Taub, R. N., Gerber, D. E., Ngov, L.-K., Yan, J., Xie, Y., & Kindler, H. L. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.05.111 · Cited by 96
Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
Hollevoet, K., Nackaerts, K., Thimpont, J., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1020oc · Cited by 95
Asbestos use and asbestos‐related diseases in Asia: Past, present and future
Le, G. V., Takahashi, K., Park, E., Vanya, D., Oak, C., Qureshi, A. M., & Aljunid, S. M. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.01975.x · Cited by 93
Domestic asbestos exposure: a review of epidemiologic and exposure data
Goswami, E., Craven, V., Dahlstrom, D., Alexander, D., & Mowat, F. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10115629 · Cited by 92
Cytologic and Bacteriologic Analysis of Fluid and Pleural Biopsy Specimens With Cope's Needle
Bueno, C. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390180034005 · Cited by 92
Mensi, C., Riboldi, L., De Matteis, S., Bertazzi, P. A., & Consonni, D. (2015) · Environment International · doi:10.1016/j.envint.2014.10.016 · Cited by 89
Pleural Mesothelioma in New Caledonia: Associations with Environmental Risk Factors
Baumann, F., Maurizot, P., Mangeas, M., Ambrosi, J.-P., Douwes, J., & Robineau, B. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002862 · Cited by 89
Gill, R. R., Umeoka, S., Mamata, H., Tilleman, T. R., Stanwell, P., Woodhams, R., Padera, R. F., Sugarbaker, D. J., & Hatabu, H. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3519 · Cited by 89
Carcinogenicity of multi-walled carbon nanotubes: challenging issue on hazard assessment
Fukushima, S., Kasai, T., Umeda, Y., Ohnishi, M., Sasaki, T., & Matsumoto, M. (2017) · Journal of Occupational Health · doi:10.1539/joh.17-0102-ra · Cited by 89
Malignant Mesothelioma Biomarkers
Creaney, J., & Robinson, B. W. S. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.12.004 · Cited by 87
BAP1, a tumor suppressor gene driving malignant mesothelioma
Cheung, M., & Testa, J. R. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.05.03 · Cited by 85
Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial
MacLeod, N. J., Chalmers, A. J., O'Rourke, N., Moore, K., Sheridan, J., McMahon, L., Bray, C. A., Stobo, J., Price, A., Fallon, M., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000499 · Cited by 84
Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma
Cheung, M., Talarchek, J. N., Schindeler, K. L., Saraiva, E., Penney, L. S., Ludman, M. D., & Testa, J. R. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.05.018 · Cited by 84
Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
Creaney, J., Olsen, N. J., Brims, F., Dick, I. M., Musk, A. W., de Klerk, N. H., Skates, S. J., & Robinson, B. W. S. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0346 · Cited by 83
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Chen, Z., Gaudino, G., Pass, H. I., Carbone, M., & Yang, H. (2017) · Translational Lung Cancer Research · doi:10.21037/tlcr.2017.05.06 · Cited by 82
Ou, S. I., Moon, J., Garland, L. L., Mack, P. C., Testa, J. R., Tsao, A. S., Wozniak, A. J., & Gandara, D. R. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000360 · Cited by 80
Papa, S., Popat, S., Shah, R. N. H., Prevost, A. T., Lal, R., McLennan, B. K., Cane, P., Lang-Lazdunski, L., Viney, Z., Dunn, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828c2b26 · Cited by 80
Edwards, J. G., Stewart, D., Martin-Ucar, A. E., et al. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.11.044 · Cited by 78
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma
Betti, M., Aspesi, A., Biasi, A., Casalone, E., Ferrante, D., Ogliara, P., Gironi, L. C., Giorgione, R., Farinelli, P., Grosso, F., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.011 · Cited by 78
Billè, A., Krug, L. M., Woo, K. M., Rusch, V. W., & Zauderer, M. G. (2015) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.10.003 · Cited by 77
Banks, D. E., Shi, R., McLarty, J. W., Cowl, C. T., Smith, D. D., Tarlo, S. M., Daroowalla, F., Balmes, J. R., & Baumann, M. H. (2009) · CHEST Journal · doi:10.1378/chest.08-1345 · Cited by 76
A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma
Rusch, V. W., Rusch, V. W., Gill, R., Mitchell, A., Naidich, D., Rice, D. C., Pass, H. I., Kindler, H. L., Perrot, M. D., Friedberg, J., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.06.069 · Cited by 76
Jahan, T. M., Gu, L., Kratzke, R. A., Dudek, A. Z., Otterson, G. A., Wang, X., Green, M., Vokes, E. E., & Kindler, H. L. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.014 · Cited by 75
Katirtzoglou, N., Gkiozos, I., Makrilia, N., Tsaroucha, E., Rapti, A., Stratakos, G., Fountzilas, G., & Syrigos, K. N. (2010) · Clinical Lung Cancer · doi:10.3816/clc.2010.n.005 · Cited by 75
Endoscopic Ultrasound-Guided Fine Needle Aspiration for Staging of Malignant Pleural Mesothelioma
Rice, D. C., Steliga, M. A., Stewart, J., et al. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.05.022 · Cited by 75
Greillier, L., Cavailles, A., Fraticelli, A., Scherpereel, A., Barlési, F., Tassi, G., Thomas, P. A., & Astoul, P. J. (2007) · Cancer · doi:10.1002/cncr.23034 · Cited by 73
Self-citationRichards, W. G., Godleski, J. J., Yeap, B. Y., et al. (2010) · Cancer · doi:10.1002/cncr.24886 · Cited by 72
Opitz, I., Friess, M., Kestenholz, P., Schneiter, D., Frauenfelder, T., Nguyen‐Kim, T. D. L., Seifert, B., Hoda, M. A., Klepetko, W., Stahel, R. A., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000661 · Cited by 71
Self-citationReNaM Working Group, Corfiati, M., Scarselli, A., Binazzi, A., Marzio, D. D., Verardo, M., Mirabelli, D., Gennaro, V., Mensi, C., Schallemberg, G., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1301-2 · Cited by 71
Matullo, G., Guarrera, S., Betti, M., Fiorito, G., Ferrante, D., Voglino, F., Cadby, G., Gaetano, C. D., Rosa, F., RUSSO, A. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061253 · Cited by 71
Laurie, S. A., Gupta, A. K., Chu, Q. S.-C., Lee, C. W., Morzycki, W., Feld, R. D., Foo, A. H., Seely, J. M., Goffin, J. R., Laberge, F., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182333df5 · Cited by 70
Marchevsky, A. M., Stang, N. L., Hiroshima, K., Pelosi, G., Attanoos, R. L., Churg, A., Chirieac, L. R., Đačić, S., Husain, A. N., Khoór, A., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.07.015 · Cited by 69
Marinaccio, A., Binazzi, A., Bonafede, M., Corfiati, M., Di Marzio, D., Scarselli, A., Verardo, M., Mirabelli, D., Gennaro, V., Mensi, C., et al. (2015) · Occupational and Environmental Medicine · doi:10.1136/oemed-2014-102297 · Cited by 68
Saddoughi, S. A., Abdelsattar, Z. M., & Blackmon, S. H. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.09.036 · Cited by 68
Bononi, I., Comar, M., Puozzo, A., Stendardo, M., Boschetto, P., Orecchia, S., Libener, R., Guaschino, R., Pietrobon, S., Ferracin, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12408 · Cited by 67
The next mesothelioma wave: Mortality trends and forecast to 2030 in Brazil
Algranti, E., Saito, C. A., Carneiro, A. P. S., Moreira, B., Mendonça, E. M. C., & Bussacos, M. A. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.08.007 · Cited by 66
Gosen, B. S. V., Blitz, T. A., Plumlee, G. S., Meeker, G. P., & Pierson, M. P. (2013) · Environmental Geochemistry and Health · doi:10.1007/s10653-012-9504-9 · Cited by 66
Bayman, N., Appel, W., Ashcroft, L., Baldwin, D., Bates, A. T., Darlison, L., Edwards, J. G., Ezhil, V., Gilligan, D., Hatton, M. Q. F., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01678 · Cited by 66
Stang, N. L., Belot, A., Ilg, A. G. S., Rolland, P., Astoul, P. J., Bara, S., Brochard, P., Danzon, A., Delafosse, P., Grosclaude, P., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24711 · Cited by 63
Self-citationDiagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: A meta-analysis
Luo, L., Shi, H., Liang, Q.-L., Jiang, J., Qin, S., & Deng, J. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.05.017 · Cited by 62
Assessment of the relationship between isocyanate exposure levels and occupational asthma
Tarlo, S. M., Liss, G. M., Dias, C., & Banks, D. E. (1997) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(199711)32:5<445::aid-ajim3>3.0.co;2-r · Cited by 61
Tan, A. L., Porcher, R., Créquit, P., Ravaud, P., & Dechartres, A. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.2109 · Cited by 61
Second line therapy in malignant pleural mesothelioma: A systematic review
Buikhuisen, W. A., Hiddinga, B. I., Baas, P., & van Meerbeeck, J. P. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.06.018 · Cited by 60
Pilling, J. E., Stewart, D. J., Martin-Ucar, A. E., et al. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2003.12.001 · Cited by 59
Dudek, A. Z., Pang, H., Kratzke, R. A., Otterson, G. A., Hodgson, L. C., Vokes, E. E., & Kindler, H. L. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318248242c · Cited by 59
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
Weber, D. G., Gawrych, K., Casjens, S., Brik, A., Lehnert, M., Taeger, D., Pesch, B., Kollmeier, J., Bauer, T. T., Johnen, G., et al. (2017) · Disease Markers · doi:10.1155/2017/9280170 · Cited by 59
Santarelli, L., Staffolani, S., Strafella, E., Nocchi, L., Manzella, N., Grossi, P., Bracci, M., Pignotti, E., Alleva, R., Borghi, B., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.021 · Cited by 57
All‐cause mortality and cancer incidence among adults exposed to blue asbestos during childhood
Reid, A., Franklin, P., Olsen, N. J., Sleith, J., Samuel, L., Aboagye‐Sarfo, P., de Klerk, N. H., & Musk, A. W. (2012) · American Journal of Industrial Medicine · doi:10.1002/ajim.22103 · Cited by 57
What is the best way to diagnose and stage malignant pleural mesothelioma?
Zahid, I., Sharif, S., Routledge, T., & Scarci, M. (2010) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2010.255893 · Cited by 57
Järvholm, B., & Alex Burdorf, A. (2015) · Scandinavian Journal of Public Health · doi:10.1177/1403494815596500 · Cited by 57
Endemic Malignant Mesothelioma: Exposure to Erionite Is More Important Than Genetic Factors
Metintaş, M., Hillerdal, G., Metintaş, S., & Dumortier, P. (2010) · Archives of Environmental & Occupational Health · doi:10.1080/19338240903390305 · Cited by 56
A genome-wide association study for malignant mesothelioma risk
Cadby, G., Mukherjee, S., Musk, A. W., Reid, A., Garlepp, M. J., Dick, I. M., Robinson, C., Hui, J., Fiorito, G., Guarrera, S., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.04.018 · Cited by 56
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
Guazzelli, A., Meysami, P., Bakker, E. Y., Demonacos, C., Giordano, A., Krstic–Demonacos, M., & Mutti, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020429 · Cited by 56
Self-citationDiagnosis and Prognosis-Review of Biomarkers for Mesothelioma
Sun, H. H., Vaynblat, A., & Pass, H. I. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.60 · Cited by 55
Campbell, N. P., Kunnavakkam, R., Leighl, N. B., Vincent, M. D., Gandara, D. R., Koczywas, M., Gitlitz, B. J., Agamah, E. S., Thomas, S. P., Stadler, W. M., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.06.011 · Cited by 55
Fennell, D. A., McDowell, C., Busacca, S., Webb, G., Moulton, B., Cakana, A., O'Byrne, K. J., van Meerbeeck, J. P., Donnellan, P. P., McCaffrey, J., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318260dfb9 · Cited by 55
Self-citationFarioli, A., Ottone, M., MORGANTI, A. G., Compagnone, G., Romani, F., Cammelli, S., Mattioli, S., & Violante, F. S. (2016) · Cancer Medicine · doi:10.1002/cam4.656 · Cited by 55
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
Ying, S., Jiang, Z., He, X., Yu, M., Chen, R., Chen, J., Ru, G., Chen, Y., Chen, W., Zhu, L., et al. (2017) · Disease Markers · doi:10.1155/2017/5756102 · Cited by 54
Bruno, C., Tumino, R., Fazzo, L., Cascone, G., Cernigliaro, A., Santis, M. D., Giurdanella, M. C., Nicita, C., Rollo, C. P., Scondotto, S., et al. (2014) · Annali dell Istituto Superiore di Sanità · doi:10.4415/ann_14_02_02 · Cited by 54
Polymorphisms of the IL-1 gene complex in coal miners with silicosis
Yücesoy, B., Vallyathan, V., Landsittel, D. P., Sharp, D. S., Matheson, J. M., BURLESON, F. G., & Luster, M. I. (2001) · American Journal of Industrial Medicine · doi:10.1002/1097-0274(200103)39:3<262::aid-ajim1014>3.0.co;2-r · Cited by 54
Nowak, A. K., Brown, C. S. B., Millward, M., Creaney, J., Byrne, M., Hughes, B. G. M., Kremmidiotis, G., Bibby, D. C., Leske, A. F., Mitchell, P. L. R., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.05.006 · Cited by 54
Hu, Z.-D., Liu, X.-F., Liu, X., Ding, C.-M., & Hu, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.02.024 · Cited by 53
Ortega-Guerrero, M. A., Carrasco‐Núñez, G., Barragán-Campos, H. M., & Ortega, M. R. (2014) · Occupational and Environmental Medicine · doi:10.1136/oemed-2013-101957 · Cited by 53
Andujar, P., Lacourt, A., Brochard, P., Pairon, J. ‐., Jaurand, M., & Jean, D. (2016) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2016.1193361 · Cited by 52
Self-citationCase–control study of pleural mesothelioma in workers with social security in Mexico
Aguilar‐Madrid, G., Robles‐Pérez, E., Juárez‐Pérez, C. A., Alvarado‐Cabrero, I., Rico-Méndez, F. G., & Kelly-García, J. (2009) · American Journal of Industrial Medicine · doi:10.1002/ajim.20780 · Cited by 51
Damhuis, R. A. M., Khakwani, A., Schutter, H. D., Rich, A. L., Burgers, J. A., & van Meerbeeck, J. P. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.05.014 · Cited by 51
Minatel, E., Trovò, M., Bearz, A., Maso, M. D., Baresic, T., Drigo, A., Barresi, L., Furlan, C., Conte, A. D., Bruschi, G., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.029 · Cited by 50
Use of Immune Checkpoint Inhibitors in Mesothelioma
Forde, P. M., Scherpereel, A., & Tsao, A. S. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0613-x · Cited by 50
Self-citationLapidot, M., Gill, R. R., Mazzola, E., Freyaldenhoven, S. T., Swanson, S., Jaklitsch, M. T., Sugarbaker, D. J., & Bueno, R. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004306 · Cited by 50
XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case–control study
Betti, M., Ferrante, D., Padoan, M., Guarrera, S., Giordano, M., Aspesi, A., Mirabelli, D., Casadio, C., Ardissone, F., Ruffini, E., et al. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.01.001 · Cited by 49
Cited by
Baas, P., Scherpereel, A., Nowak, A. K., Fujimoto, N., Peters, S., Tsao, A. S., Mansfield, A. S., Popat, S., Jahan, T., Antonia, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32714-8 · Cited by 1,215
Self-citationUpdate on biology and management of mesothelioma
Asciak, R., George, V., & Rahman, N. M. (2021) · European Respiratory Review · doi:10.1183/16000617.0226-2020 · Cited by 75
The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review
Désage, A.-L., Karpathiou, G., Peoc’h, M., & Froudarakis, M. E. (2021) · Cancers · doi:10.3390/cancers13133205 · Cited by 34
Metadata
- Authors
- Scherpereel, A., Opitz, I., Berghmans, T., Psallidas, I., Glatzer, M., Rigau, D., Astoul, P., Bölükbas, S., Boyd, J., Coolen, J., De Bondt, C., De Ruysscher, D., Durieux, V., Faivre-Finn, C., Fennell, D., Galateau-Salle, F., Greillier, L., Hoda, M. A., Klepetko, W., Lacourt, A., McElnay, P., Maskell, N. A., Mutti, L., Pairon, J.-C., Van Schil, P., van Meerbeeck, J. P., Waller, D., Weder, W., Cardillo, G., & Putora, P. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2020-05-25
- Volume
- 55
- Issue
- 6
- Pages
- 1900953
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W3028094831
- Cited by
- 273
- References
- 285
- FWCI
- 20.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.